株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

緑内障治療薬レポート (2019年):世界市場の分析 2018年〜2024年

2019 Glaucoma Pharmaceuticals Market Report: A Global Analysis for 2018 to 2024

発行 Market Scope, LLC 商品コード 644810
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.58円で換算しております。
Back to Top
緑内障治療薬レポート (2019年):世界市場の分析 2018年〜2024年 2019 Glaucoma Pharmaceuticals Market Report: A Global Analysis for 2018 to 2024
出版日: 2019年06月11日 ページ情報: 英文
概要

世界の緑内障治療薬市場は、2024年までの複合年間成長率 (CAGR) が5.1%になることが見込まれています。

当レポートでは、世界の緑内障治療薬市場を展望しており、急成長が見込まれる市場と伸び悩む可能性の高い市場、眼科医を補佐する存在である検眼医の役割の拡大、発展途上国における緑内障への新たな関心の高まり、診断率を高める最新の診断技術などについて分析しています。

調査対象地域(国)

  • 米国
  • 西欧
  • 日本
  • その他先進国
  • 中国
  • インド
  • ラテンアメリカ
  • 他の地域

調査トピック

  • 緑内障の種類とリスク要因
  • 疾病の診断と治療
  • 眼科医と検眼医を含む世界の緑内障医療提供者の状況
  • 世界の患者数の現時点での見積もりと今後5年間の予測
  • 現在販売されている緑内障治療薬とその作用機序
  • ジェネリック医薬品とブランド医薬品についての議論と市場への影響
  • 緑内障治療薬開発のパイプライン
  • 緑内障治療薬を製造、販売している企業の概要
目次

What's New

In the 2019 Glaucoma Pharmaceuticals Market Report, now in its sixth edition, Market Scope forecasts that revenues in the global glaucoma pharmaceuticals market will grow with a CAGR of 5.1 percent to 2024. In the report, we examine growth in the fastest and slowest markets, the growing role of optometrists as ophthalmologist-extenders, new attention to glaucoma in developing countries, and new diagnostic technologies, which will increase the diagnostic rate.

Description

The 2019 Glaucoma Pharmaceuticals Report is Market Scope's comprehensive analysis of the glaucoma pharmaceutical segment of ophthalmology. Our report is designed for members of the ophthalmic industry who participate in this market or are weighing doing so, market analysts, ophthalmologists who treat glaucoma patients, investors, and any other parties who may be interested in the global marketplace of glaucoma pharmaceuticals.

The 2019 Glaucoma Pharmaceuticals Market Report provides provides analysis of current markets for glaucoma medications and forecasts market performance over the next five years. We analyze the global market based on Market Scope's eight regional/economic categories, and we also use these categories in our global forecasts for disease prevalence. The report explores data and information on the disease process, glaucoma populations, glaucoma care, and a range of additional topics intended to provide depth and context to the reader's understanding of this ophthalmic segment. Our coverage includes:

  • Types of glaucoma and risk factors.
  • Diagnosis and treatment of the disease.
  • A global view of glaucoma care providers, including ophthalmologists and optometrists.
  • Current estimates and five-year forecasts for disease prevalence worldwide.
  • Glaucoma medications in the marketplace and their mechanisms of action.
  • Discussion of generic versus branded drugs and their market impact.
  • The development pipeline for glaucoma pharmaceuticals.
  • Profiles of companies making and marketing glaucoma medications.

image1

Author Profile

Peter Downs

image1

Peter Downs has more than 30 years of experience as a business and medical journalist and investigative reporter. He has written for a variety of medical industry publications, including the Medical Business Journal, CBS HealthWatch, and Oncology News International.


Prior to joining Market Scope in 2015 and turning his attention to ophthalmology, Peter analyzed markets for organ and tissue transplantation. Since joining Market Scope, he has traveled to several markets outside the US, including China, Europe, and India, to study ophthalmology at the local level.

In addition to his research and writing efforts on the ophthalmic market, he is also a contributor to Ophthalmic Market Perspectives,

Our report provides analysis of current markets for glaucoma medications and forecasts market performance over the next five years. We analyze the global market based on Market Scope's eight regional/economic categories (US, Western Europe, Japan, Other Wealthy Nations, China, India, Latin America, and Rest of World), and we also use these categories in our global forecasts for disease prevalence. In addition, we explore data and information on the disease process, glaucoma populations, glaucoma care, and a range of additional topics intended to provide depth and context to the reader's understanding of this ophthalmic segment. Our coverage includes:

  • Types of glaucoma and risk factors;
  • Diagnosis and treatment of the disease;
  • A global view of glaucoma care providers, including ophthalmologists and optometrists;
  • Current estimates and five-year forecasts for disease prevalence worldwide;
  • Glaucoma medications in the marketplace and their mechanisms of action;
  • Discussion of generic versus branded drugs and their market impact;
  • The development pipeline for glaucoma pharmaceuticals;
  • Profiles of companies making and marketing glaucoma medications.
Back to Top